Pages that link to "Q37061262"

The following pages link to Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice (Q37061262):

Displaying 29 items.

• Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline (Q26784170) (← links)
• Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities (Q27338799) (← links)
• APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). (Q30455082) (← links)
• Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice (Q33688727) (← links)
• Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration (Q34110890) (← links)
• Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. (Q34218993) (← links)
• Increased expression of SVCT2 in a new mouse model raises ascorbic acid in tissues and protects against paraquat-induced oxidative damage in lung (Q34256535) (← links)
• Does vitamin C deficiency affect cognitive development and function? (Q34263572) (← links)
• A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism. (Q34314213) (← links)
• Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome (Q34360485) (← links)
• Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease (Q34994270) (← links)
• Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics. (Q35589042) (← links)
• Neuronal and vascular oxidative stress in Alzheimer's disease (Q35687039) (← links)
• Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice (Q35764820) (← links)
• Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures (Q36866566) (← links)
• Effects of SuperUlam on Supporting Concentration and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study (Q37393158) (← links)
• High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice (Q37620654) (← links)
• Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice. (Q37693458) (← links)
• Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants. (Q38253060) (← links)
• Oxidative stress, serotonergic changes and decreased ultrasonic vocalizations in a mouse model of Smith-Lemli-Opitz syndrome (Q38755055) (← links)
• Oxidative stress signaling to chromatin in health and disease. (Q42123491) (← links)
• Vitamin C Status and Cognitive Function: A Systematic Review (Q42368222) (← links)
• Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models (Q46255391) (← links)
• The Mechanism of Memory Enhancement of Acteoside (Verbascoside) in the Senescent Mouse Model Induced by a Combination of D-gal and AlCl3. (Q48217084) (← links)
• Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease (Q50746664) (← links)
• Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration (Q58571187) (← links)
• Assessment of Improvement in Oxidative Stress Indices with Resocialization in Memory Retrieval in Y-Maze in Male Rats (Q60933329) (← links)
• Plasma Vitamin C Concentrations and Cognitive Function: A Cross-Sectional Study (Q64084275) (← links)
• Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer's disease (Q94570175) (← links)